Table 1 The baseline characteristics of study population.

From: Low neutrophil-to-lymphocyte ratio identifies secondary polycythemia in patients with erythrocytosis

 

Total (n = 655)

PV (n = 168)

SP (n = 487)

p value

Age (years)

54.68 ± 15.46

65.47 ± 11.68

50.96 ± 14.85

< 0.001

Male

527 (80.46%)

92 (54.76%)

435 (89.32%)

< 0.001

BMI (kg/m2)

25.71 ± 4.1

23.83 ± 3.54

26.38 ± 4.07

< 0.001

Current smoker

206 (31.45%)

15 (8.93%)

191 (39.22%)

< 0.001

JAK2 positive

165 (25.19%)

165 (98.21%)

0 (0%)

< 0.001

Laboratory data

 WBC (/µL)

9775.82 ± 5253.35

15,230.06 ± 7013.58

7894.27 ± 2530.56

< 0.001

  Neutrophil (%)

61.96 ± 12.16

74.82 ± 9.09

57.52 ± 9.67

< 0.001

  Lymphocyte (%)

27.14 ± 10.94

15.04 ± 7.24

31.32 ± 8.67

< 0.001

  Absolute neutrophil count (/µL)

6462.44 ± 4831.80

11,720.72 ± 6453.40

4648.49 ± 2061.80

< 0.001

  Absolute lymphocyte count (/µL)

2290.84 ± 831.17

1993.78 ± 729.18

2393.32 ± 840.19

0.031

 Hemoglobin (g/dL)

18.22 ± 1.36

18.4 ± 1.78

18.15 ± 1.18

0.0864

 Hematocrit (%)

54.13 ± 4.58

57.08 ± 5.54

53.12 ± 3.69

< 0.001

 Platelet (/µL)

309,834.35 ± 212,901.82

555,410.71 ± 287,301.16

225,118.07 ± 67,778.47

< 0.001

 CRP (mg/dL)

0.31 ± 1.28

0.31 ± 1.27

0.31 ± 1.28

0.9725

NLR

3.44 ± 4.07

6.72 ± 5.57

2.24 ± 2.45

< 0.001

 Subnormal EPO

139 (21.55%)

115 (71.88%)

24 (4.95%)

< 0.001

  1. EPO erythropoietin, JAK2 janus kinase 2, NLR neutrophil-to-lymphocyte ratio, PV polycythemia vera, SP secondary polycythemia.